Position in ALGS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,707,072
+$1,584,906 QoQ
Shares Held
229,754
+1652.8% QoQ
Ownership
6.40%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALGS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ALGS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,707,072 | 229,754 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $122,166 | 13,108 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $18,757 | 1,914 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $18,832 | 2,612 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,274,649 | 154,503 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,354 | 285 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $59,329 | 6,851 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $285,610 | 816,029 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,124,772 | 1,147,727 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $762,113 | 1,147,762 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $859,219 | 1,150,227 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,117,566 | 1,150,945 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,003,161 | 1,147,783 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,096,090 | 1,150,148 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,262,955 | 1,148,142 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,376,702 | 1,137,771 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,546,154 | 1,184,258 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,820,237 | 1,164,300 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $523,134 | 33,729 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $341,324 | 16,744 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $443,701 | 19,512 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $237,983 | 8,607 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||